# Smith Bids Farewell to the Only Company Built Entirely Around HIV - Date: 2026-03-31 - Category: Biotech & Life Sciences Thirty years in HIV. Thirteen at ViiV. The injectable franchise she built is now facing Gilead's twice-yearly lenacapavir — and the scientist who built it is leaving. ---